Botanix Pharmaceuticals Limited (BOT.AX)
- Simply Wall St.
Botanix Pharmaceuticals Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag
Botanix Pharmaceuticals ( ASX:BOT ) Full Year 2024 Results Key Financial Results Net loss: AU$13.9m (loss widened by...
- Simply Wall St.
Unveiling Three ASX Growth Companies With High Insider Ownership
The Australian stock market is currently experiencing a downturn, with the ASX200 down by 0.45% and most sectors showing declines. Notably, IT and healthcare sectors have faced significant losses, while real estate has shown some resilience amidst recent economic turbulence highlighted by a surprising inflation report. In such a market context, companies with high insider ownership can be particularly compelling as they often indicate that those closest to the business are confident in its...
- Simply Wall St.
ASX Growth Companies With High Insider Ownership And Up To 120% Earnings Growth
The Australian market has shown varied performance recently, with the ASX200 modestly increasing by 0.1% over the past week. Notably, sectors such as IT and financials have seen gains, while materials faced declines. In this context of fluctuating sector performance, companies with high insider ownership can be particularly compelling. These firms often benefit from aligned interests between shareholders and management, which might be crucial in navigating through current market conditions...
